Synthesis of novel N-(aryl) diazenyl thiazol-2-amines and bezylidenethiazolidin- 4-ones linked to indole nucleus as antioxidant, antimicrobial, antimycobacterial and cytotoxic agents

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 2, 2014, Pages 141-147

  Saundaneanand, R ^a   Prabhakerwalmik, ^a   Kirankumar, N M ^a   Annapurna, H ^a  

^a GULBARGA UNIVERSITY   (India)

Author keywords

Anti mycobacterial; Antimicrobial; Antioxidant; Cytotoxic activities; Indole; Thiazolidin 4 one

Indexed keywords

2 N (2 PHENYL 1H INDOL 3 YL) IMINO 4 ARYLTHIAZOLE DERIVATIVE; 3 (4 (4 CHLOROPHENYL) THIAZOL 2 YL) 5 (4 METHOXYBENZYLIDENE) 2 (2 PHENYL 1H INDOL 3 YL)THIAZOLIDIN 4 ONE; 3 (4 (4 CHLOROPHENYL) THIAZOL 2 YL) 5 (4 NITROBENZYLIDENE) 2 (2 PHENYL 1H INDOL 3 YL) THIAZOLIDIN 4 ONE; 3 (ARYLTHIAZOL 2 YL) 2 (2 PHENYL 1H INDOL 3 YL) THIAZOLIDIN 4 ONE DERIVATIVE; 4 (4 CHLOROPHENYL) N [((4 METHOXYPHENYL) DIAZENYL](2 PHENYL 1H INDOL 3 YL)METHYLENE]THIAZOL 2 AMINE; 4 (4 CHLOROPHENYL) N [[(4 CHLOROPHENYL) DIAZENYL](2 PHENYL 1H INDOL 3 YL)METHYLENE]THIAZOL 2 AMINE; 5 (4 CHLOROBENZYLIDENE) 2 (2 PHENYL 1H INDOL 3 YL) 3 (4 P TOLYLTHIAZOL 2 YL)THIAZOLIDIN 4 ONE; 5 (4 CHLOROBENZYLIDENE) 2 (2 PHENYL 1H INDOL 3 YL) 3 (4 PHENYLTHIAZOL 2 YL) THIAZOLIDIN 4 ONE; 5 (4 CHLOROBENZYLIDENE) 3 (4 (4 CHLOROPHENYL) THIAZOL 2 YL) 2 (2 PHENYL 1H INDOL 3 YL) THIAZOLIDIN 4 ONE; 5 (4 METHOXYBENZYLIDENE) 2 (2 PHENYL 1H INDOL 3 YL) 3 (4 P TOLYLTHIAZOL 2 YL) THIAZOLIDIN 4 ONE; 5 (4 METHOXYBENZYLIDENE) 2 (2 PHENYL 1H INDOL 3 YL) 3 (4 PHENYLTHIAZOL 2 YL) THIAZOLIDIN 4 ONE; 5 (4 NITROBENZYLIDENE) 2 (2 PHENYL 1H INDOL 3 YL) 3 (4 P TOLYLTHIAZOL 2 YL)THIAZOLIDIN 4 ONE; 5 (4 NITROBENZYLIDENE) 2 (2 PHENYL 1H INDOL 3 YL) 3 (4 PHENYLTHIAZOL 2 YL) THIAZOLIDIN 4 ONE; FLUCONAZOLE; GENTAMICIN; INDOLE DERIVATIVE; N [(2 PHENYL 1H INDOL 3 YL)(P TOLYLDIAZENYL]METHYLENE] 4 P TOLYLTHIAZOL 2 AMINE; N [[(4 CHLOROPHENYL)DIAZENYL](2 PHENYL 1H INDOL 3 YL)METHYLENE] 4 P TOLYLTHIAZOL 2 AMINE; N [[(4 METHOXYPHENYL)DIAZENYL](2 PHENYL 1H INDOL 3 YL)METHYLENE] 4 P TOLYLTHIAZOL 2 AMINE; PYRAZINAMIDE; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; ASPERGILLUS ORYZAE; ASPERGILLUS TERREUS; BROTH DILUTION; CELL CULTURE; CHELATION; CYTOTOXICITY; DPPH RADICAL SCAVENGING ASSAY; ESCHERICHIA COLI; INFRARED SPECTROSCOPY; MASS FRAGMENTOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; MTT ASSAY; MYCOBACTERIUM TUBERCULOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SYNTHESIS; THIN LAYER CHROMATOGRAPHY;

EID: 84897133941     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the begining). Free radical Research 1999; 31: 261-272.
2. Babizhayev MA, Deyev AI, Yermakova VN, Brikman IV, Bours J. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes. Drugs in R and D 2004; 5: 125-139.
3. Liu L, Meydani M. Combined vitamin C and E supplementation retards early progression of arteriosclerosis in heart transplant patient. Nutr Rev 2002; 60: 368-371.
4. K. Siddappa, Prashant C. Hanamshetty, Sunilkumar B. Mane, Nagabhushana M. M. Development and validation of spectrophotometric method for the Determination of cyclophosphamide in bulk drug and its pharmaceutical Dosage form. Int J Pharm PharmSci, 2013; 4: 597-600.
5. Cozzi P. The discovery of a new potential anticancer drug: a case history. Farmaco2003; 58: 213-220.
6. Johnsto SRD, Ford H, Ross P. In the royal Marsden hospital hand book of cancer chemotherapy. Elsevier, London, New York, Oxford (2005).
7. Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998; 4: 195-199.
8. Singh P, Mishra AK, Malonia SK, Chauhan DS, Sharma VD, Venkatesan K, Katoch VM. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria. J Commun Dis 2006; 38(3): 288-298.
9. Bajtos B, Yu M, Zhao H, Pagenkopf BL. C-2/C-3 annulation and C-2 alkylation of indoles with 2-alkoxycyclopropanoate esters. J Am ChemSoc2007; 129: 9631-9634.
10. Bittner S, Scherzer R, Harlev E. The five bromotryptophans. Amino Acid 2007; 33: 19-42.
11. Stansfield I, Pompei M, Conte I, Ercolani C, Migliaccio G, JairajM, Giuliano C, Rowley M, Narjes F. Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med ChemLett2007; 17: 5143-5149.
12. Li YY, Wu HS, Tang L, Feng CR, Yu JH, Li Y, Yang YS, Yang B, He QJ. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. Pharmcol Res 2007; 56: 335-343.
13. Weng JR, Tsai CH, Kulp SK, Wang D, Lin CH, Yang HC, Ma Y, Sergeants A, Chiu CF, Tsai MH, Chen CS. A potent indole-3-carbinol-derived antitumor agent with pleiotropic effect on multiple signaling pathways in prosrage cancer cells. Cancer Res 2007; 67: 7815-7824.
14. Furukawa S, Usuda K, Abe M, Hayashi S, Ogawa I. Indole-3-acetic acid induces microencephaly in mouse fetuses. ExpToxicolPathol2007; 59: 43-52.
15. Singh RK, Lange TS, Kim K, Zou Y, Lieb C, Sholler GL, Brard L. Effect of indole ethyl isothiocyanates on proliferation, apoptosis, and MAPK signaling in neuroblastoma cell lines. Bioorg Med ChemLett2007; 17: 5846-5852.
16. Elmegeed GA, Khalli WKB, Raouf AA, Abdelhalim MM. Synthesis and in vivo anti-mutagenic activity of novel melatonin derivatives. Eur J Med Chem2007; 43: 763-770.
17. Fukutomi J, Fukuda A, Fukuda S, Hara M, Terada A, Yoshida M. Scavenging activity of indole compounds against cisplatininduced reactive oxygen species. Life Sci2006; 80: 254-257.
18. Kruk I, Aboul-Enein HY, Michalska, Lichszteld TK, Kubasik-Kladna K, Olgen S In vitro scavenging activity for reactive oxygen species by N-substituted indole-2-carboxylic acid esters. Luminescence 2007; 22: 379-386.
19. Matuszak ZK, Reszka J, Chignell CF. Reaction of melatonin and related indoles with hydroxyl radicals: ERP and spin trapping investigations. Free RadicBiol Med 1997; 23: 367-372.
20. Geronikaki A, Hadjipavlou-Litina D. In vitro studies of some 2, 4-disubstituted thiazolylaminoketones with anti-inflammatory activity. Correlation with lipophilicity and structural characteristics. ArzneimForsc Drug Res 1996, 46: 1134-1137.
21. Geronikaki A, Hadjipavlou-LitinaD. Lipophilicity and antiinflammatory activity of some 2-(aminoacetylamino)thiazole derivatives. Pharmazie1993; 48: 948-949.
22. Saundane AR, Veresha PM Sharma. Synthesis and Antimicrobial Activity of 2-(2', 5'-substituted indolodineamino-3'-yl)-4, 6-diarylpyrimidines and 2-[(2', 5'-substitute dindole-3'-yl(Phenylazomethyleneimino}-4, 6-diaryl pyrimidines. Indian J HeterocyclChem2004; 13: 275-276.
23. Saundane AR, Yarlakatti M, Prabhaker W, Katkar V. Synthesis, Antimicrobial and Antioxidant Activities of IndolylPyrazoles. Indian J Heterocycl Chem. 2012; 21: 255-258.
24. Saundane AR, Yarlakatti M, Prabhaker W, Katkar V. Synthesis, antioxidant and antimicrobial evaluation of thiazolidinone, azetidinone encompassing indolylthienopyrimidines. Journal of Chemical Sciences 2012, 124(2): 469-481.
25. Saundane AR, Prabhaker W. Synthesis, Antioxidant, Antimicrobial, Antimycobacterial, and Cytotoxic Activities of Azetidinone and Thiazolidinone Moieties Linked to Indole Nucleus. Journal of Chemistry 2013; http://dx. doi. org./10. 1155/2013/543815.
26. Nisha S, Sudhir KB, Ashok K. Thiazolyl/oxazolylformazanylindoles as potent antiinflammatory agents. Eur J Med Chem2008; 43: 2597-2609.
27. National Communities for Clinical laboratory Standard (NCCLS). 940, Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA, Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement 2002; (ISBN 1-56238-454-6), M100-S12 (M7).
28. Maria CSL, Souza MVN De, Alessandra C. Evaluation of antitubercular activity of nicotinic and isoniazid analogues. ARKIVOK 2007; 15: 181-191.
29. Hatano T, Kangawa H, Yasuhara T, Okuda T. Two new favonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. Chemical & Pharmaceutical Bulletin 1988; 36(6): 2090-2097.
30. Oyaizu M. Antioxidative activity of browning substances on glucosamine. Japan Nutrition 1986; 44(6): 307-315.
31. Dinis TCP, Maderia VMC, Almeida LM. Action of phenolic derivatives (acetoaminophen, salycilate, and 5-aminosalycilate) as inhibitors of membrane lipid peroxidation and as proxy radical scavengers. Archives of Biochemistry and Biophysics 1994; 315: 161-169.
32. Dolly A, Griffiths JB Cell and Tissue Culture for Medical Research, John Wiley & Sons.
33. 2 enrichment and foliar application of salicylic acid on the production and antioxidant activities of anthocyanin, flavonoids and isoflavonoids from ginger. Int J MolSci2012; 13: 14828-14844.